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ABSTRACT
Conjunctival melanoma potentially deadly tumor. While many cases of 
conjunctival melanoma appeared to be a recurrence, there is no valid data 
about parameters to predict the recurrence of this tumor. This study intended 
to evaluate whether histopathologic features can be used as a predictor 
for recurrence in conjunctival melanoma. This was a retrospective study, 
involving patients with conjunctival melanoma by the year 2013-1017 in Dr. 
Sardjito General Hospital and Dr. Yap Eye Hospital, Yogyakarta. Patient’s 
characteristic was determined by age, sex, laterality, tumor size, tumor location, 
histopathological dominancy, MMC application, recurrence, and metastases. 
Sixteen cases were found: male (62.5%) and female (37.5%). Age from 5-79 
years, mean was 56.19 years. Tumor location was in bulbar in 11 patients 
(68.7%), palpebral in 5 patients (31.3%).There was significant association 
between metastasis and the tumor recurrence (OR 13.0; 95% CI 1.9-85.4; p = 
0.007). A favorable trend of association was also found between location and 
the recurrence of melanoma (OR 15.0; 95% CI 0.9-228.8; p = 0.06). In summary, 
our study showed that the patients that developing distant metastasis were at 
a greater risk for tumor recurrence.
ABSTRAK
Melanoma konjungtiva berpotensi mematikan. Sementara banyak kasus 
konjungtiva melanoma tampaknya berulang, ada data yang valid tentang 
parameter untuk memprediksi kekambuhan tumor ini. Penelitian ini 
dimaksudkan untuk mengevaluasi apakah gambaran histopatologis dapat 
digunakan sebagai prediktor untuk rekurensi pada melanoma konjungtiva. 
Ini adalah penelitian retrospektif, yang melibatkan pasien dengan melanoma 
konjungtiva pada tahun 2013-1017 di Rumah Sakit Umum Sardjito dan Rumah 
Sakit Mata Yap. Karakteristik pasien ditentukan oleh usia, jenis kelamin, 
lateralitas, ukuran tumor, lokasi tumor, dominasi histopatologis, aplikasi 
MMC, rekurensi, dan metastasis. Enam belas kasus ditemukan: laki-laki 
(62,5%) dan perempuan (37,5%). Usia dari 5-79 tahun, rata-rata adalah 56,19 
tahun. Lokasi tumor berada di bulbar pada 11 pasien (68,7%), palpebral 
pada 5 pasien (31,3%). Ada hubungan yang signifikan antara metastasis 
dan rekurensi tumor (OR 13,0; 95% CI 1,9-85,4; p = 0,007). Kecenderungan 
hubungan yang menguntungkan juga ditemukan antara lokasi dan 
kekambuhan melanoma (OR 15.0; CI 95% 0,9-228,8; p = 0,06). Singkatnya, 
penelitian kami menunjukkan bahwa pasien yang mengembangkan 
metastasis jauh berada pada risiko lebih besar untuk kekambuhan tumor. 
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INTRODUCTION
Conjunctival melanoma was an 
uncommon malignancy with significant 
morbidity and mortality.1 The annual 
incidence of conjunctival melanoma 
in the world was between 0.2-0.5 cases 
per 1.000.000 people. The earlier study 
in Indonesia found that the incidence of 
melanoma in male and female was 1:1.5.2 
Conjunctival melanoma considerably 
rare in children younger than 15 years.3 
Another study reported that conjunctival 
melanoma was a potentially deadly 
tumor. This previous study shown that the 
metastasis of the conjunctival melanoma 
was detected in 26% of patients, while 
13% of patients were death in 10 years.1,4 
Although, the understanding of the 
biology mechanism that involve in 
conjunctival melanoma was hindered by 
a lack of adequate correlation between 
clinical and histological features of this 
particular neoplasm.5
Conjunctival melanoma typically 
presents as a pigmented nodular or flat 
conjunctival lesion, however there are 
cases of amelanotic tumors that may 
confuse the clinical picture and delay 
diagnosis.3 It may arise from primary 
acquired melanosis with atypia or de 
novo. Histologically, cellular morphology 
in melanomas may range from spindle 
to epithelioid.6 Esmaeli, et al. reported 
that the epithelioid type is correlated 
with higher morbidity.1 Histopathology 
examination remains the gold standard 
for the definitive diagnosis for 
conjunctival melanoma.7 The review 
of several studies, showed a number of 
histopathological features were found to 
be associated with increased recurrence 
of a malignant lesion.8-10 Certain histologic 
features may also predict the prognosis of 
conjunctival melanoma. Purely spindle 
type lesion have been associated with 
a more favorable prognosis than mixed 
cell type lesion.11-13
There are several clinical features 
that reported related to the melanoma 
recurrence. The association between 
metastasis and melanoma recurrence 
were reported in previous study.14,15 
Other studies also mentioned the 
association of melanoma recurrence 
with the location of the tumor.16,17 Several 
studies also showed that the male gender 
was more affected and associated with 
tumor recurrence.18-20 While many cases 
of conjunctival melanoma appeared to 
be recurrence, there is valid data about 
parameters to predict the recurrence 
of this tumor. To date, there is limited 
study that analyzed the correlation 
between clinical features of conjunctival 
melanoma and its recurrences in 
Indonesia. Our study aimed to evaluate 
the correlation between the clinical 
features of conjunctival melanoma and 
its recurrences in Indonesia. 
MATERIALS AND METHODS
Study design and population
This cross-sectional retrospective 
study involved 16 cases conjunctival 
melanoma presented between 2013−2017 
at Dr. Sardjito General Hospital and 
Dr. Yap Eye Hospital, Yogyakarta. All 
the patients underwent a surgery and 
the entire surgical specimen were sent 
to pathology department for further 
examination. The tumor specimens 
were examined with minimum of five 
high-power fields. Prior specimens 
from our institution were reviewed in 
the patients submitted with recurrent 
lesions. All specimens were defined as 
conjunctival melanoma according to 
WHO classification that confirmed with 
pathological examination reviewed by at 
least 2 pathologists.21 All the patients that 
found to be diagnosed with conjunctival 
melanoma were enrolled, while 
choroidal and uveal melanoma cases 
were excluded from this study. Current 
study reviews the age, sex, laterality, 
tumor size, tumor location, mitomycin-C 
(MMC) application, recurrence, and 
metastases data that taken from medical 
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records. Predominant histopathological 
features (epithelioid vs spindle) of 
conjunctival melanoma were also 
reviewed according to previous study.1 
Ethical approval
This study was approved by The 
Medical and Health Research Ethics 
Committee (MHREC), Faculty of Medicine, 
Public Health and Nursing, Universitas 
Gadjah Mada, Yogyakarta and followed 
the basic principles of the Declaration of 
Helsinki (2008).
Statistical analyses
The pooled data were then analyzed 
using SPSS 24 for descriptive quantitative 
results and correlation using Spearman 
correlation test. p value less than 0.05 
was considered statistically significant. 
Data were presented as frequencies or 
mean ± standard deviation (SD).
RESULTS
Demographic data for all patients 
enrolled in this study were summarized 
in TABLE 1. Among patients enrolled 
in this study, 37.5% were female and 
62.5% were male. The mean age of the 
patients was 56.2 (SD±23.34) years. 
We found 11 (68.7%) patients showed 
a bulbar conjunctiva tumor, while 5 
(31.3%) patients were exhibit tumor in 
palpebral conjunctiva. The predominant 
histopathology features that found 9 
(56.3%) patients were mixed type which 
include both of spindel and epithelial cell. 
Meanwhile, the spindle type melanoma 
was found in 6 (37.5%) patients and the 
epithelioid type in 1 (6.3%) patient. In 
this study, we found 4 (25%) patients that 
presented with a recurrence lesion. The 
distant metastases were also found in 3 
(18.8%) patients.
TABLE 1. Patient’s characteristic
Parameter Frequency Percentage (%)
Gender
•	 Female 6 37.5
•	 Male 10 62.5
Age
•	 < 50 years 5 31.3
•	 ≥ 50 years 11 68.7
Tumor size 
(cm3)
•	 < 1 7 43.7
•	 ≥ 1 9 56.3
Predominant 
histopathologic 
features
•	 Spindle 6 37.4
•	 Epithelioid 1 6.3
•	 Mixed 9 56.3
MMC
•	 Yes 11 68.7
•	 No 5 31.3
Laterality
•	 Right eye 8 50
•	 Left eye 8 50
Location
•	 Bulbar 11 68.7
•	 Palpebral 5 31.3
Metastases
•	 Yes 3 18.8
•	 No 13 71.2
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TABLE 2. Association of several factors with the recurrence of melanoma
Characteristic Total Recurrence (%) n = 4
Non-recurrence 
(%) n=12 p OR (95% CI)
Gender
•	 Female 6 3 (75) 3 (25)
•	 Male 10 1 (25) 9 (75) 0.11 9.0 (0.6-122.7)
Age group
•	 < 50 years 5 1 (25) 4 (33.3)
•	 ≥ 50 years 11 3 (75) 8 (66.7) 1.00 0.6 (0.1-19.4)
Location
•	 Bulbar 11 1 (25) 10 (83.3)
•	 Palpebra 5 3 (75) 2 (16.7) 0.06 15.0 (0.9-228.8)
Tumor size
•	 < 1 cm3 7 1 (25) 6 (50)
•	 ≥ 1 cm3 9 3 (75) 6 (50) 0.58 3.0 (0.2-37.6)
MMC Application
•	 No 5 2 (50) 3 (25)
•	 Yes 11 2 (50) 9 (75) 0.55 0.3 (0.03-3.5)
Histology
•	 Spindel 6 2 (50) 4 (33.3)
•	 Epithelioid 1 0 (0) 1 (8.3)
•	 Mixed 9 2 (50) 7 (58.3) 0.744
Metastasis
•	 No 26 1 (25) 12 (100)
•	 Yes 11 3 (75) 0 (0) 0.007 13.0 (1.9-85.4)
There was significant association 
between metastasis and the recurrence 
of melanoma (OR 13.0; 95% CI 1.9-85.4; p 
= 0.007). A favorable trend of association 
was also found between location and the 
recurrence of melanoma (OR 15.0; 95% 
CI 0.9-228.8; p = 0.06). The association 
between melanoma recurrences 
with gender, age group, tumor size, 
MMC application and predominant 
histopathological were analyzed, but 
none of them showed a significant 
association. 
DISCUSSIONS
A proper clinical examination with 
slit lamp biomicroscopy that includes 
the size, color, focality, laterality, 
borders, elevation, feeder vessels and 
location of the lesion with drawings 
for documentation is essential for 
diagnosing ocular melanoma, although 
a tissue biopsy is required for a definite 
diagnosis.22 Our study revealed that 
there was significant association 
between metastasis and the recurrence 
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of melanoma and also a favorable trend 
of association between location and the 
recurrence of melanoma. A metastasis 
was reported as the most common 
form (40%) of melanoma recurrence.14 
Other study also has shown that the 
only parameter significantly associated 
metastasis of melanoma was tumor 
recurrence.15 Thus, the patients that 
exhibit metastasis have higher risk of 
tumor recurrence. 
Interestingly, our study also 
showed a marginally significance in 
the association of tumor location with 
the melanoma recurrence. A study of 
150 subjects showed that the location 
of the tumor was a predictive factor for 
tumor recurrence.16 A similar study also 
showed that non-limbal location of the 
primary tumor was a predictive factor 
for local recurrence.17 In agreement with 
the previous study, the tumor location 
might be attributable to the recurrence 
of melanoma.
We found no correlation between 
gender and the recurrence of melanoma. 
In our study we found male were more 
affected than female, but this has no 
correlation with disease recurrence. 
Other various studies also showed no 
predilection for either gender, while 
some had shown greater association 
with male gender.18,19 A study that 
enrolled 1.156 adults diagnosed with 
melanoma, reported that females has 
more advantage prognostic factors in 
melanoma. This study was used amitotic 
rate of melanomaas the prognostic factor 
for recurrence, although the results only 
showed marginally significance data.20 
Therefore, the gender might not relate to 
the recurrence of melanoma.
Next, we look for a correlation 
between predominant histopathological 
features with the recurrence of 
melanoma. Our study showed that 
there was no correlation between 
predominant histopathological features 
and conjunctival melanoma recurrence. 
There was also no correlation found 
between predominant histopathological 
features and metastases of conjunctival 
melanoma. There was no other study 
specifically mentioned the correlation 
between predominant histopathological 
features with neither recurrence and 
metastases of conjunctival melanoma. A 
study managed to report the correlation 
between predominant histopathological 
features and metastases of conjunctival 
melanoma. In that study, the 
predominant epithelioid cells features on 
histopathological examination was tend 
to have higher rate of metastases.12 The 
variation of the results between current 
study with the previous study could be 
affected from the race and the risk factor 
for melanoma in different region.
MMC application used as an adjuvant 
therapy to reduce the likelihood of 
disease recurrence.23 Our study showed 
that MMC application has no correlation 
with tumor recurrence and distant 
metastases. Limitations of this study 
were the small sample size and unequal 
follow up time for each patient. Further 
study in conjunctival melanoma is 
needed to find other factors that may lead 
to the prediction of disease recurrence 
and distant metastases.
CONCLUSION
In this study, our results showed 
that the patients with a history of distant 
metastasis were at the greater risk for 
tumor recurrence. Thus, the distant 
metastasis might be a strong predictor 
for the recurrence of the diseases.
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